Vol. 105, No. 1, 1982
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Pages 28-35
March 15, 1982
TRANSPOrt OF 5-OXOPROLINE INTO RABBIT RENAL BRUSH BORDER MEMBRANE VESICLES VadiveL
Ganapathy,
R.
August
Roesei* and Frederick H. Leibach
Department of Cell and Molecular Biology Medical College of Georgia Augusta, Georgia 30912 and *Gracewood State School and Hospital Gracewood, Georgia 308[2
Received January 19, 1982
5-Oxoproline has been shown to be +transported intact into rabbit renal brush border membrane vesicles by a Na -gradient dependent mechanism. The transport occurs against a concentration gradient. The equilibrium transport of 5-oxoproline decreases with increasing medium osmolarity. The predominant portion of transport occurs into an osmotically responsive intravesicular space, the non-specific surface binding being negligible. Competition experiments show that transport of 5-oxoproline is inhibited by most of the neutral amino acids whereas acidic, basic and imino acids do not have any effect.
Introduction: 5-Oxoproline,
also known as pyrrolidone carboxylic acid or pyroglutamic
acid is a cyclic amino acid present in free form in all animal tissues and also at the N-terminus of a number of naturally occurring, biologically active peptides and proteins.
The metabolic formation and utilization of 5-oxoproline
in the y-glutamyl cycle have been reviewed (i).
This amino acid is produced
in free form independently by the action of at least three enzymes - y-glutamyl cyclotransferase
(I), pyrrolidonyi carboxypeptidase (2,3) and y-glutamylamine
cyclotransferase
(4).
most
5-oxoproline as the N-terminal residue of proteins is
likely formed late in protein synthesis by cyclization of N-terminal
glutamine
(5).
Utilization of 5-oxoproline is initiated by the action of
5-oxoprolinase which converts 5-oxoproline to glutamic acid (6). 5-Oxoproline is present in all animal tissues and plasma. 5-oxoproline in the mouse tissues is 20-50 ~M (7).
The level of
It is also a major water
soluble nitrogen compound in the epidermis where its concentration is at least ten times higher (8).
The urinary excretion of 5-oxoproline is 1 ~mole per mg
0006-291X/82/050028-08501.00/0 Copyright © 1982byAcadem~ Pre~,lnc. AHrigh~ofreproduction m anyform reserved.
28
Vol. 105, No. 1, 1982 creatinine
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
in the mouse
(7) and 820 ~mole per mg creatinine
in man (9).
The
tissue and plasma levels of 5-oxoproline and its excretion in urine increases many
fold in patients with 5-oxoprolinuria
synthetase deficiency An interesting
(i0) or 5-oxoprolinase feature
associated with either glutathione deficiency
of 5-oxoprolinuria
(11,12).
is the accompanying
level of proline and other amino acids in the plasma
(13,14).
elevated
It was suggested
that there may be competitive
interactions between proline and 5-oxoproline
metabolism
However, no data are available on the transport
or transport
of 5-oxoproiine across
and its interaction with other amino acids during transport
any cellular
teristics
of
(7).
in
membrane.
5-oxoproline
We report here for the first time the charac-
transport
in kidney,
using purified
renal brush
border membrane vesicles from rabbit.
Methods and Materials Rabbit renal brush border membrane vesicles were prepared as described previously (15,16). The purity of the memb;anes was routinely evaluated by specific marker enzymes (16) and occasionally by electron microscopy. Only the membranes completely free from basal-lateral membrane contamination as assessed by the absence of (Na+-K +) ATPase activity were used. Transport was assayed by the Millipore filtration technique described in detail elsewhere (15). When the effect of various amino acids on transport was studied, the pH of the solutions in each case was adjusted to 7.5 with either HC1 or Tris base. Plasma 5-oxoproline was determined as glutamic acid after hydrolysis as described by Hagenfeldt et al. (17). 200 DI of deproteinized plasma was passed through a column (6 x 0.6 cm) of Dowex 50 W x 4 (50-100 mesh) and the 5-oxoproline eluted with 3 ml of water. The eluate was mixed with 3 ml of 5 N HCI and hydrolyzed for i hr at 100°C. The solution was evaporated to dryness and I ml of sodium citrate buffer (200 mM, pH 2.1) added and analyzed on the amino acid analyzer (Beckman Model 120-C). Urine 5-oxoproline was measured as previously described (ii). The organic acids in the urine were isolated on a DEAE-Sephadex column and eluted with 1.5 M pyridinium acetate buffer, pH 5.0. The eluate was evaporated to dryness and the organic acids esterified with 14% boron trifluoride in n-butanol. The butyl esters were then separated and quantified by gas chromatography (Varian, model 3700) using a 6% diethyleneglycol succinate column. 5-Oxoprolinase activity was determined by the method of Stromme and Eldjarn (18). The intravesicular contents were extracted as described in (19) and analyzed for 5-oxoproiine and glutamic acid (17). [14C(U)]-5-oxoproline (286 mCi/mmol) was purchased from New England Nuclear. Unlabeled 5-oxoproline was from Sigma. Other amino acids were from California Corporation for Biochemicals. All other reagents were of analytical grade. 29
Vol. 105, No. 1, 1982
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Results and Discussion Plasma and urinary levels of 5-oxoproline. the plasma and urinary analyzed
the
levels
of 5-oxoproline
There is no data available on in the rabbit.
rabbit plasma and urine for their 5-oxoproline
concentration
of 5-oxoproline
We, therefore, content.
The
in the plasma was 30 ~M and the urinary excretion
was 0.36 ~mole/mg creatinine. 5-Oxoprolinase activity. is catalyzed by 5-oxoprolinase contain very high activities nmol/hr/mg protein
protein
in an ATP-dependent
Mammalian kidneys
of this enzyme.
the 5-oxoprolinase
as
in the purified
activity
of 5-oxoprolinase
nmol/hr/mg
5-oxoprolinase
protein
Since
in
the transport
version of 5-oxoproline
of giutamic
activity
and
border
in the homogenate
membrane
the trace activity
to glutamic
acid during
vesicles.
added
of 5-oxoproline
to glutamic
was maximal
the
Fig.
The amount
Glutamic acid in However, with
of glutamic acid (0.0006 nmol) were clear that there is no appreciable
acid under the normal transport assay
1 represents
the
typical pattern of
(20 ~M) into brush border membrane vesicles in NaCI
+ a Na -gradient.
vesicles
traces
It is, therefore,
5-0xoproline
of
with
We followed the formation
levels after 30 sec incubation.
(30 minute),
of 5-oxoproline
presence
Since
associated
to the incubation medium was 3 nmol.
in the medium.
KCI media.
and
the regular transport assay
would be negligible.
conditions. TTansport of 5-oxoproline. transport
protein
The specific
assays were carried out in the absence of ATP, con-
membranes
incubation
conversion
vesicles.
the cytosolic contamination.
the medium was below detectable
detected
In the present study, we
in the rabbit renal cortex homogenate
the brush enzyme,
and il nmol/hr/mg
acid in the incubation medium as a function of time.
of 5-oxoproline
prolonged
(20,21)
(8).
was 13 nmol/hr/mg
represents
the purified
The reported value is about 30
brush border membrane
is a soluble
purified membranes
reaction.
in the rat kidney homogenate
as well
using
to glutamic acid
in the guinea pig kidney homogenate
determined
0.03
The conversion of 5-oxoproline
exhibited The
the
'overshoot'
accumulation
of 5-oxoproiine
at 30 sec and then decreased
30
phenomenon
in the
inside the
due to the effiux of the
Vol. 105, No. 1, 1982
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
c
915 E o
E
c
0
'
,//-r-/~r-
Incubation Time (minutes) Fig. L
Time
course
of 5-oxoproLine
trausport
in NaCi and KCi media.
The vesicles were incubated with labeled 5-oxoproline varying periods of time in NaCi and KCi media. -
(20 pM) for
- NaC~ medium
o---o KCi medium
amino acid. of
No overshoot
5-oxoproline
in KCI
phenomenon
medium
was
was observed
in KCI medium.
lower than the transport
The transport
in NaCI m e d i u m
at
+
all
the
initial
transport line
(30 min)
the vesicles
and At
this
final
the peak
5-oxoproline
was
min
the
incubation.
transport
was
incubation
was found
medium
reached
The
Na -dependent
the
overshoot,
twice
space,
to be
of the results
the
the
was
The
of
non-specific
to infinite
osmolarity
3]
at prolonged
incubation
in both NaCi and KCI concentration
transport the m e d i u m to
binding
of
value.
to the membranes
proportional
of
of 5-oxopro-
intravesicular
equilibrium
stimulation
The amount
the same
binding
as a function
inversely
2).
value
that of the equilibrium
non-specific
measured
(Fig.
an equilibrium
level of transport
between
intravesicular
incubation)
polation
of
almost
To distinguish into
of
was 13 fold at 15 sec and 6 fold at 30 sec.
inside
media.
periods
the
and
transport
of 5-oxoproline osmolarity. osmolarity
calculated
by
(30 The
of
the
extra-
was 15% of the transport
observed
VOI. 105, No. I, 1982
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
1,5-
,= x
~I0o c
05-
Osmolarity"1 Fig.
Effects of mediu~ osmolarity on the initLal transport of 5-oxoproiine in NaCi medium.
2
and equilibrium
To calculate the initia$ rates of transport, the vesicles were first preequilibrated in Na -free medium of varying osmolarities for 30 min. The vesicles were then incubated with labeled 5-oxoproline (20 uM) for 30 see. in respective osmolar solutions containing NaCI. To calculate the equilibrium transport, the vesicles were directly incubated with labeled 5-oxoproline (20 ~M) for 30 min in NaCI medium of varying osmoiarities. Initial rates of transport o----o Equilibrium transport
at
300 mosm.
studied
using
+
Na -free assay. but
The
effect
a 30
media
of osmolarity
sec
incubation.
of varying
The initial
the binding
was
less
predominant
portion
osmotically
responsive
Intravesicular 30 sec incubation
of
The vesicles
osmolarities
transport
before
rates varied
than
of transport
total
was
pre-equilibrated
in the transport
with osmolarity
transport
at
therefore,
in
(Fig.
300 mosm. occurs
2),
The
into
an
space.
Analysis
of the vesicles
rates
they were used
transport,
intravesicular
were
inversely
5% of the
5-oxoproline
contents.
on the initial
with
of
the
20 u M
intravesicular
contents
[±4C]-5-oxoproline
after
in the presence
+ of a Na -gradient form
of
glutamic
showed
5-oxoproline. acid was
that more
Only
trace
than
99% of the radioactivity
amounts
detected.
32
of radioactivity
was
in the
in the
form
of
Vol. 105, No. 1, 1982
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS Tab Le 1
Effects of other amino acids on the initial rates of Na -~ependent 5-oxoproiine transport
Addition
Relative Transport
None Isoleucine Alanine Valine Tryptophan Serine GLutamine 5-o×oproiine Pheny[aianine Threonine Methionine Leucine Pro[ine Hydroxyproline Glycine Lysine Arginine Giutamic acid Aspartic acid Pipecolic acid Glycyl-proiine
i00 37 ± 7 40 ± 8 46 ± 7 49 i 4 51 ± i3 57 i 2 57 i 9 58 ± 2 61 i 5 67 i 2 80 i 5 75 i 8 102 ± 5 104 ± 5 i13 i 7 116 ~ 9 i02 ± 9 i04 i 4 i04 i 3 112 ± Ii
Renal brush border membrane vesicles were incubated with labeled 5-oxoproline (20 ~M) at 25°C for 30 sec in NaCI and KCI media. The concentration of unlabeled amino acids in the incubation medium was 2 mM. The Na -dependent 5-oxoproline transport was calculated by substracting the transport observed in KCI medium from the transport in NaCI medium. The control value for the Na+-dependent transport was 18.4 i 1.8 pmol/mg protein and this was taken as i00.
Effects the
effects
transport
of
of
markedly caused
of other amino acids acidic
5-oxoproline.
inhibited
The
basic
Na+-dependent
transport
amino
a small but highly
reproducible
inhibition while
aspartic
acid
transport. hydrolysis inhibition. acids
basic amino acids and
glutamic
Pipecolic by
renal These
share
border
results a
common
of
membrane
clearly
show
transport
except
glycine.
vesicles that
33
Proline
hydroxyproline
and the acidic
had no
amino acids
on 5 - o x o p r o l i n e
a d i p e p t i d e h i g h l y resistant (19)
did
5-oxoproline
mechanism
border membrane.
I shows
5 - o x o p r o l i n e was
also did not have any effect
acid and g l y c y l - p r o l i n e , brush
acids
lysine and arginine
acid
Table
amino acids and imino acids on the
the neutral
The
by
and
transport.
all
effect.
amino
neutral,
on 5 - o x o p r o l i n e
in
the
not
and
rabbit
cause
the renal
any
neutral brush
to
Vol. 105, No. I, 1982
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
The inhibition, Because would
though weak,
of the structural
expect
Glycine,
a greater
proline
by proline
similarities
inhibition
of
and hydroxyproline
system in the kidney.
However,
is an interesting observation.
between proline and 5-oxoproline, 5-oxoproline
are known
transport
by proline.
to share a common
transport
a number of recent investigations
show that
proline also interacts with many neutral amino acids during transport. has been shown to inhibit membranes
(22).
phenylalanine,
surprising.
Proline
alanine transport in the rabbit renal brush border
Similarly,
a number
cause significant
kidney (23,24).
one
of
neutral
amino
acids,
especially
inhibition of proline transport
in the rabbit
The inhibition caused by proiine is, therefore,
not altogether
This may be one of the possible reasons for the elevated plasma
concentration of proline in 5-oxoprolinuria. Pipecolic animals. acid,
acid has
There
proline
and
5-oxoprolinuria competition present
are
long been known as a product of lysine metabolism in
significant
structural
5-oxoproline.
associated
with
between proline
study shows
Our
similarities
recent
findings
5-oxoprolinase
and pipecolic
that pipecolic
between pipecolic
with a patient with
deficiency
acid during
(ii)
suggested
transport.
acid does not compete with
But,
the
5-oxoproline
during transport. The data presented ciently
reabsorb
tration
gradient,
Once inside
5-oxoproline thus
the tubular
of 5-oxoprolinase
in this paper show that the rabbit kidney can effifrom the glomerular filtrate against a concen-
effectively cells,
avoiding
its elimination
in the urine.
it can be utilized because of the high levels
activity in the renal tissue.
Acknowledgements: This study was supported in part Research Grants AM[3L50 and FR-5365.
by National
Institutes
of Health
References: I. 2. 3. 4.
Van der Werf, P. and Meister, A. (1975) Adv. Enzymol., 4 3 Arme~Itrout, R.W. and Doolittie, R.F. (1969) Arch. Biochem. 132 80-90. Szewczuk, A. and Kwiatkowska, J. (i970). Eur. J. Biochem., Fink, M.L., Chung, S.I. and Folk, J.E. (1980) Proc. Natl. (USA), 77 4564-4568. 34
519-566. Biophys., 1 5 92-96. Acad. Sci.
Vol. 105, No. I, 1982 5. 6. 7. 8. 9. I0. ii. i2. 13. 14. 15. 16. [7. i8. 19. 20. 21. 22. 23. 24.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Abraham, G.N. and Podell, D.N. (1981) Mol. Ceil. Biochem., 3 8 181-190. Van der Werf, P., Orlowski, M. and Meister, A. (1971) Proc. Natl. Acad. Sci. (USA), 68 2983-2985. Van der Werf, P., Stephani, R.A. and Meister, A. (1974) Proc. Natl. Acad. Sci. (USA), 71 1026-1029. Wolfersberger, M.G. and Tabachnick, J. ([974) J. Invest. Dermatol., 62 587-590. Oberholzer, V.G., Wood, C.B.S., Palmer, T. and Harrison, M.B. (1975) Clin. Chim. Acta., 62 299-304. Wellner, V.P., Sekura, R., Meister, A. and Larsson, A. (1974) Proc. Natl. Acad. Sci. (USA), 71 2505-2509. Roesel, A., Hommes, F.A. and Samper, L. (1981) J. Inher. Metab. Dis., 4 89-90. Larsson, A., Mattsson, B., Wauters, E.A.K., Van Gool, J.D., Duran, M. and Wadman, S.K. (1981) Acta Paediatr. Scand. 70 301-308. Eldjarn, L., Jellum, E. and Stokke, O. (1972) Clin. Chim. Acta, 4 0 461-476. Marstein, S. and Terry, T.L. (1981) Clin. Chim. Acta., 109 13-20. Ganapathy, V., Mendicino, J. and Leibach, F.H. (1981) J. Biol. Chem., 256 i18-i24. Ganapathy, V., Mendicino, J. and Leibach, F.H. (1981) Biochim. Biophys. Acta., 642 381-391. Hagenfeldt, L., Larsson, A. and Anderson, R. (1978) N. Eng. J. Med., 299 587-590. Strophe, J.H. and Eldjarn, L. (1972) Scand. J. Clin. Lab. Invest., 29 225-342. Ganapathy, V., Mendicino, J., Pashley, D.H. and Leibach, F.H. (1980) Biochem. Biophys. Res. Commun., 97 I133-Ii39. Wendel, A. and Flugge, U.I. (1975) Noppe Seyler's Z. Physiol. Chem., 356 873-880. Van der Werf, P., Griffith, O.W. and Meister, A. (1975) J. Biol. Chem., 250 6686-6692. Fass, S.J., Hammerman, M.R. and Sacktor, B. (1977) J. Biol. Chem., 252 583-590. McNamara, P., Ozegovic, B., Pepe, L.M. and Segal, S. (1976) Proc. Natl. Acad. Sci. (USA) 73 4521-4525. Hammerman, M.R. and Sacktor, B. (1977) J. Biol. Chem., 252 591-595.
35